Market closed· · HKD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
As global markets navigate a complex landscape of economic resilience and inflationary pressures, the Asian market continues to capture investor interest with its diverse opportunities. Penny stocks, though an outdated term, remain relevant for those seeking growth potential in smaller or newer companies. By focusing on financial strength and growth prospects, investors can uncover compelling opportunities among these often-overlooked stocks.
Taimei Technology (HK.02576), a leading AI-powered drug clinical development platform company, and C&R Research (A359090), a top-tier CRO in South Korea, signed an enterprise-level strategic partnership agreement, officially launching the development of an AI-based clinical trial operations system.
Amidst global economic fluctuations, Asian markets have been navigating a landscape of both challenges and opportunities. While major indices experience volatility, investors are increasingly turning their attention to lesser-known segments like penny stocks. Although the term "penny stocks" might seem outdated, these smaller or newer companies can offer significant value when backed by strong financials. In this article, we explore three Asian penny stocks that stand out for their financial...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.